Medicine and Dentistry
Atrial Fibrillation
100%
Patient
91%
Tachyarrhythmia
81%
Catheter Ablation
40%
Ezetimibe
39%
Follow up
39%
Endothelial Dysfunction
36%
Pulmonary Vein
32%
Drug-Eluting Stent
29%
Brain
29%
Atrioventricular Block
29%
Statin
29%
Combination Therapy
28%
Recurrent Disease
28%
Plaque
25%
Coronary Stenting
24%
Diseases
24%
Arm
21%
Therapeutic Procedure
20%
Oxysterol
20%
QRS Complex
19%
Polyvinylchloride
19%
Ventricular Outflow Tract
19%
Coronary Artery
19%
Sinus Rhythm
18%
Dabigatran
18%
Blood Stasis
14%
Intravascular Ultrasound
14%
Angiotensin II
14%
Faintness
14%
Canakinumab
14%
Rho Kinase
14%
Experience
13%
Inpatient
12%
Lipid
12%
Monotherapy
12%
Incidence
12%
Low Density Lipoprotein Cholesterol
12%
Coronary Artery Disease
12%
Cardiovascular System
11%
26 Hydroxycholesterol
11%
Antithrombotic
11%
Development
11%
Depressor Response
11%
Stent
11%
Observation
9%
Morphology
9%
thought
9%
Coronary Sinus
9%
Coronary Angiography
8%
Biochemistry, Genetics and Molecular Biology
Atrial Fibrillation
93%
Oxysterol
37%
Statin
36%
Association
33%
Structure Analysis
29%
Cholesterol Metabolism
29%
Cholesterol
23%
Absorption
23%
Electric Potential
22%
Ultrasound
14%
Hemostasis
14%
Campesterol
14%
Bigeminy
14%
Synthesis
13%
27-Hydroxycholesterol
11%
Time
11%
Effective Refractory Period
7%
Anticoagulation
7%
Partial Thromboplastin Time
7%
Prothrombin
7%
Lipid
7%
Ablation of Atrial Fibrillation
7%
Cholesterol Synthesis
6%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
75%
Placebo
29%
Statin (Protein)
29%
Idarucizumab
29%
Ezetimibe
18%
Dabigatran
18%
Angiotensin II
14%
Canakinumab
14%
Lipid
12%
Clinical Trial
11%
Rat
11%
26 Hydroxycholesterol
11%
Campesterol
11%
Anticoagulant Agent
11%
Hypertension
7%
Receptor
7%
Oxysterol
7%
Heart Tamponade
7%
Prothrombin
7%
Clotting Time
7%
Bleeding
7%